JOURNAL HOME CME HOME THIS MONTH PAST ISSUES ETOC COLLECTIONS
AUTHORS REVIEWERS EDITORIAL BOARD FEEDBACK RSS HELP
A&A International Anesthesia Research Society
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ishikawa, A.
Right arrow Articles by Hatano, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ishikawa, A.
Right arrow Articles by Hatano, Y.
Related Collections
Right arrow Mechanisms
Right arrow Physiology
Right arrow Pharmacology

Anesth Analg 2007;105:97-102
© 2007 International Anesthesia Research Society
doi: 10.1213/01.ane.0000265851.37923.ec

ANESTHETIC PHARMACOLOGY

The Mechanism Behind the Inhibitory Effect of Isoflurane on Angiotensin II-Induced Vascular Contraction Is Different from That of Sevoflurane

Ai Ishikawa, MD, Koji Ogawa, MD, Yasuyuki Tokinaga, MD, Nobuhiko Uematsu, MD, Kazuhiro Mizumoto, MD, and Yoshio Hatano, MD

From the Department of Anesthesiology, Wakayama Medical University, Wakayama, Japan.

Address correspondence and reprint requests to Koji Ogawa, MD, Department of Anesthesiology, Wakayama Medical University, 811-1 Kimiidera, Wakayama 641-0012, Japan. Address e-mail to ogawak{at}wakayama-med.ac.jp.

BACKGROUND: Angiotensin II (Ang II)-induced vascular contraction is mediated both by a Ca2+-mediated signaling pathway and a Ca2+ sensitization mechanism. We recently demonstrated that sevoflurane inhibits the contractile response to Ang II, mainly by inhibiting protein kinase C (PKC) phosphorylation that regulates myofilament Ca2+ sensitivity, without significant alteration of intracellular Ca2+ concentration ([Ca2+]i) in rat aortic smooth muscle. The current study was designed to determine the mechanisms by which isoflurane inhibits Ang II-induced contraction of rat aortic smooth muscle.

METHODS: The effects of isoflurane on vasoconstriction, increase in [Ca2+]i, and phosphorylation of PKC in response to Ang II (10–7 M) were investigated, using an isometric force transducer, a fluorometer, and Western blotting, respectively.

RESULTS: Ang II elicited a transient contraction of rat aortic smooth muscle that was associated with an increase in [Ca2+]i and PKC phosphorylation. Isoflurane (1.2%–3.5%) inhibited Ang II-induced contraction of rat aortic smooth muscle in a concentration-dependent manner (P < 0.05 at 1.2%, P < 0.01 at 2.3% and 3.5% isoflurane, n = 6). Isoflurane also inhibited elevation of [Ca2+]i in response to Ang II (P < 0.01 at 2.3% and 3.5% isoflurane, n = 6), but failed to affect Ang II-induced phosphorylation of PKC at concentrations up to 3.5% (n = 7).

CONCLUSION: These results suggest that, unlike sevoflurane, the inhibitory effect of isoflurane on Ang II-induced contraction is mainly mediated by attenuation of the Ca2+-mediated signaling pathway.






Lippincott, Williams & Wilkins Anesthesia & Analgesia® is published for the International Anesthesia Research Society® by Lippincott Williams & Wilkins with the assistance of Stanford University Libraries' HighWire Press®. Copyright 2006 by the International Anesthesia Research Society. Online ISSN: 1526-7598   Print ISSN: 0003-2999 HighWire Press
Copyright © 2007 by the International Anesthesia Research Society.